Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer

Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer

Conditions: Pancreatic Cancer
Interventions: Biological: GVAX pancreas vaccine
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The Skip Viragh Foundation; National Cancer Institute (NCI)
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 27, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments